Two Advanced Prostate Cancer Treatment Options Available at Gibson Cancer Center

Two Advanced Prostate Cancer Treatment Options Available at Gibson Cancer Center

Published on September 22, 2026

UNC Health Southeastern's Gibson Cancer Center continues to redefine what cancer care can look like in a rural community. With the addition of advanced treatment options for prostate cancer, patients can receive increasingly sophisticated therapies close to home. This is care that requires most other rural communities to travel to a larger metropolitan or academic medical center.

Gibson Cancer Center continues to expand the depth and complexity of cancer care available in our region, combining innovative treatment options with the convenience, personal attention, and support of a local care team. These advances add treatment options giving patients more choices and reducing the disruption cancer care can create. Gibson Cancer Center is demonstrating that exceptional, advanced cancer care is available right here in southeastern North Carolina.

One of these options is stereotactic body radiotherapy, an advanced form of radiation therapy that uses highly precise imaging and treatment planning to deliver powerful doses of radiation directly to prostate tumors. Unlike traditional radiation treatments that can require 20 to 45 visits, stereotactic body radiotherapy can often be completed in as few as five treatment sessions. This shorter treatment schedule may help reduce time away from work and family while providing outcomes comparable to more traditional radiation therapy approaches.

Another advanced treatment available at Gibson Cancer Center is Pluvicto®, a targeted radiopharmaceutical therapy for certain patients with advanced prostate cancer. The therapy is used to treat prostate cancer that has spread beyond the prostate and continues to grow despite hormone therapy. The treatment works by identifying a specific marker found on prostate cancer cells and delivering radiation directly to those cells throughout the body, helping target cancer while limiting exposure to healthy tissue.

For patients and families unfamiliar with the medical terminology, Pluvicto is approved for men whose cancer has spread to other parts of the body, is no longer responding to standard hormone-blocking treatments, and carries a marker on the cancer cells that allows Pluvicto to target them directly.

These prostate cancer treatment options are part of the center's comprehensive cancer program, which combines advanced technology with a multidisciplinary approach to care. Patients have access to on-site PET/CT imaging, laboratory and pharmacy services, infusion therapies, advanced radiation treatment technology and a team of specialists who work together to develop individualized treatment plans. Patients and families also benefit from support services, including social workers and financial navigators who can assist with non-clinical needs throughout the cancer journey.

Gibson Cancer Center continues to demonstrate that living in a rural community does not have to mean accepting fewer options for cancer care. UNC Health Southeastern is building a cancer program that brings increasingly sophisticated technology, treatments and expertise to southeastern North Carolina. Our ambition is to make Gibson Cancer Center a destination for exceptional cancer care, one that gives patients more reasons to stay here for treatment and fewer reasons requiring the need to leave our region to find it.

If you or a loved one has been diagnosed with prostate cancer, talk with your urologist, oncologist or primary care provider about whether stereotactic body radiotherapy or Pluvicto therapy may be appropriate treatment options. To learn more about prostate cancer services available at UNC Health Southeastern's Gibson Cancer Center, visit https://www.unchealthsoutheastern.org/care-treatment/cancer/ or call (910) 671-5730.